These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16051036)

  • 1. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent.
    Cron GO; Wallace JC; Stevens WD; Fortin T; Pappas BA; Wilkins RC; Kelcz F; Santyr GE
    Magn Reson Imaging; 2005 Jun; 23(5):619-27. PubMed ID: 16051036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes.
    Boos M; Scheffler K; Haselhorst R; Reese E; Fröhlich J; Bongartz GM
    J Magn Reson Imaging; 2001 Apr; 13(4):568-76. PubMed ID: 11276101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
    Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
    Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
    Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
    Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
    Ruehm SG; Christina H; Violas X; Corot C; Debatin JF
    Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial concentration profiles of two blood pool agents and Gd-DOTA after intravenous injection in rabbits.
    Corot CA; Violas X; Robert P; Port M
    Acad Radiol; 2002 May; 9 Suppl 1():S137-9. PubMed ID: 12019850
    [No Abstract]   [Full Text] [Related]  

  • 15. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.
    Jia G; Heverhagen JT; Henry H; Polzer H; Baudendistel KT; von Tengg-Kobligk H; Levine AL; Rosol TJ; Knopp MV
    Magn Reson Imaging; 2006 Jul; 24(6):721-5. PubMed ID: 16824967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance angiography: first-pass arterial enhancement as a function of gadolinium-chelate concentration, and the saline chaser volume and injection rate.
    Husarik DB; Bashir MR; Weber PW; Nichols EB; Howle LE; Merkle EM; Nelson RC
    Invest Radiol; 2012 Feb; 47(2):121-7. PubMed ID: 21934516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation.
    Drapé JL; Thelen P; Gay-Depassier P; Silbermann O; Benacerraf R
    Radiology; 1993 Jul; 188(1):227-34. PubMed ID: 8511303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.